Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
The Journal of Experimental Medicine|June 11, 2024
Personalized cancer T-cell therapy takes the stage, mirroring vaccine successJohanna Chiffelle, Alexandre HarariFrontiers in Immunology|August 16, 2021
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer PatientsMarion Arnaud, Sara Bobisse, Johanna Chiffelle, et al.Current Opinion in Biotechnology|September 5, 2020
T-cell repertoire analysis and metrics of diversity and clonalityJohanna Chiffelle, Raphael Genolet, Marta As Perez, et al.Cell Death and Differentiation|June 3, 2017
RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiationJawahar Kopparam, Johanna Chiffelle, Paolo Angelino, et al.Vaccines|June 6, 2020
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based VaccinesMichele Graciotti, Fabio Marino, HuiSong Pak, et al.Immunity|October 10, 2023
Machine learning methods and harmonized datasets improve immunogenic neoantigen predictionMarkus Müller, Florian Huber, Marion Arnaud, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 19, 2024
Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDistMarta A S Perez, Johanna Chiffelle, Sara Bobisse, et al.Cell Reports Methods|May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRsRaphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.Nature Biotechnology|November 16, 2021
Sensitive identification of neoantigens and cognate TCRs in human solid tumorsMarion Arnaud, Johanna Chiffelle, Raphael Genolet, et al.NPJ Vaccines|March 16, 2021
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancerJanos L Tanyi, Cheryl L-L Chiang, Johanna Chiffelle, et al.Pageof 2